MYELOMAPP 14
Risk assessment for newly diagnosed, fit and young patients with Multiple Myeloma, in the era of novel treatment modalities: Are there any additional factors to be under consideration?
Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Hashim, Salman Harbi, Analie Estanislao, Solaf Ka
Adult Hematology & Stem Cell Transplantation Department, King Fahad Specialist Hospital
Lido
1277
Vezesque se leu este artigo
545
Total PDF
732
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 17 | 9 | 26 |
| 2025 5 | 51 | 11 | 62 |
| 2025 4 | 44 | 17 | 61 |
| 2025 3 | 51 | 12 | 63 |
| 2025 2 | 39 | 26 | 65 |
| 2025 1 | 30 | 13 | 43 |
| 2024 12 | 31 | 13 | 44 |
| 2024 11 | 29 | 17 | 46 |
| 2024 10 | 32 | 20 | 52 |
| 2024 9 | 42 | 12 | 54 |
| 2024 8 | 39 | 24 | 63 |
| 2024 7 | 32 | 17 | 49 |
| 2024 6 | 35 | 23 | 58 |
| 2024 5 | 34 | 21 | 55 |
| 2024 4 | 30 | 16 | 46 |
| 2024 3 | 17 | 16 | 33 |
| 2024 2 | 13 | 24 | 37 |
| 2024 1 | 14 | 17 | 31 |
| 2023 12 | 11 | 16 | 27 |
| 2023 11 | 17 | 25 | 42 |
| 2023 10 | 7 | 22 | 29 |
| 2023 9 | 14 | 28 | 42 |
| 2023 8 | 13 | 14 | 27 |
| 2023 7 | 8 | 17 | 25 |
| 2023 6 | 15 | 15 | 30 |
| 2023 5 | 13 | 21 | 34 |
| 2023 4 | 8 | 2 | 10 |
| 2023 3 | 8 | 12 | 20 |
| 2023 2 | 5 | 9 | 14 |
| 2023 1 | 7 | 12 | 19 |
| 2022 12 | 9 | 18 | 27 |
| 2022 11 | 5 | 8 | 13 |
| 2022 10 | 12 | 18 | 30 |
Mostrar tudo
